ARMATA PHARMACEUTICALS, INC. Total Liabilities and Equity
ARMATA PHARMACEUTICALS, INC. (ARMP) had Total Liabilities and Equity of $89.95 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-12
- 2026-06-30: Liabilities and Equity $89.95M.
- 2026-03-31: Liabilities and Equity $69.80M.
- 2025-12-31: Liabilities and Equity $76.88M.
- 2025-09-30: Liabilities and Equity $89.52M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $89.95M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $69.80M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $76.88M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $89.52M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $80.79M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $87.25M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $86.44M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $98.24M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $108.31M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $120.36M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $98.36M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $112.76M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $101.21M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $108.78M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $95.83M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $92.88M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $100.98M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $107.77M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $69.77M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $42.67M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $48.28M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $52.84M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $39.52M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $45.67M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $49.46M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $44.10M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $25.45M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $29.30M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $34.92M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $9.62M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $14.54M 10-K · filed 2020-03-19 | $11.89M 10-K · filed 2019-03-25 |
| 2018-09-30 | $10.62M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $11.72M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $14.40M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $11.14M 10-K · filed 2019-03-25 | |
| 2017-09-30 | $13.78M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $15.11M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $14.30M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $18.15M 10-K · filed 2018-03-14 | $18.20M 10-K · filed 2017-03-27 |
| 2016-09-30 | $26.04M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $29.28M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $28.26M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $31.49M 10-K · filed 2017-03-27 | |
| 2015-09-30 | $34.08M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $36.37M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $38.60M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $28.62M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $31.93M 10-Q/A · filed 2015-04-15 | $28.42M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $34.72M 10-Q/A · filed 2015-04-15 | $31.26M 10-Q · filed 2014-09-12 |
| 2014-03-31 | $37.55M 10-Q/A · filed 2015-04-15 | $34.35M 10-Q · filed 2014-05-20 |
| 2013-12-31 | $41.21M 10-Q/A · filed 2015-04-15 | $37.95M 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |